Mathew GE

References (6)

Title : Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease - Mathew_2020_J.Biomol.Struct.Dyn__1
Author(s) : Mathew GE , Oh JM , Mohan K , Tengli A , Mathew B , Kim H
Ref : J Biomol Struct Dyn , :1 , 2020
Abstract : Mathew_2020_J.Biomol.Struct.Dyn__1
ESTHER : Mathew_2020_J.Biomol.Struct.Dyn__1
PubMedSearch : Mathew_2020_J.Biomol.Struct.Dyn__1
PubMedID: 32588753

Title : Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases - Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
Author(s) : Mathew B , Parambi DGT , Mathew GE , Uddin MS , Inasu ST , Kim H , Marathakam A , Unnikrishnan MK , Carradori S
Ref : Arch Pharm (Weinheim) , :e1900177 , 2019
Abstract : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
ESTHER : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
PubMedSearch : Mathew_2019_Arch.Pharm.(Weinheim)__e1900177
PubMedID: 31478569

Title : Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones - Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
Author(s) : Parambi DGT , Aljoufi F , Murugaiyah V , Mathew GE , Dev S , Lakshminarayanan B , Hendawy OM , Mathew B
Ref : Cent Nerv Syst Agents Med Chem , 19 :67 , 2019
Abstract : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
ESTHER : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
PubMedSearch : Parambi_2019_Cent.Nerv.Syst.Agents.Med.Chem_19_67
PubMedID: 30451121

Title : Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole - Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
Author(s) : Mathew B , Baek SC , Thomas Parambi DG , Lee JP , Mathew GE , Jayanthi S , Vinod D , Rapheal C , Devikrishna V , Kondarath SS , Uddin MS , Kim H
Ref : Arch Pharm (Weinheim) , :e1800309 , 2019
Abstract : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
ESTHER : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
PubMedSearch : Mathew_2019_Arch.Pharm.(Weinheim)__e1800309
PubMedID: 30663112

Title : Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review - Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
Author(s) : Mathew B , Parambi DGT , Sivasankarapillai VS , Uddin MS , Suresh J , Mathew GE , Joy M , Marathakam A , Gupta SV
Ref : CNS Neurol Disord Drug Targets , 18 :432 , 2019
Abstract : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
ESTHER : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
PubMedSearch : Mathew_2019_CNS.Neurol.Disord.Drug.Targets_18_432
PubMedID: 31187716

Title : Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors - Mathew_2018_Medchemcomm_9_1871
Author(s) : Mathew B , Baek SC , Grace Thomas Parambi D , Pil Lee J , Joy M , Annie Rilda PR , Randev RV , Nithyamol P , Vijayan V , Inasu ST , Mathew GE , Lohidakshan KK , Kumar Krishnan G , Kim H
Ref : Medchemcomm , 9 :1871 , 2018
Abstract : Mathew_2018_Medchemcomm_9_1871
ESTHER : Mathew_2018_Medchemcomm_9_1871
PubMedSearch : Mathew_2018_Medchemcomm_9_1871
PubMedID: 30568755